Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-469-2 | CAS number: 12237-63-7 This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 45160:2.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Data is from study report.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: * OECD No. 471 (July 21, 1997) * EEC Directive 92/69, B14 and B13 (December 1992)
- Principles of method if other than guideline:
- Standard plate test and Preincubation test was performed to determine the mutagenic nature of the test chemical
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Ferrate(4-), hexakis(cyano-C)-, Et 2-[6-(ethylamino)-3-(ethylimino)-2,7-dimethyl-3H-xanthen-9-yl]benzoate copper(2+) salts
- EC Number:
- 235-469-2
- EC Name:
- Ferrate(4-), hexakis(cyano-C)-, Et 2-[6-(ethylamino)-3-(ethylimino)-2,7-dimethyl-3H-xanthen-9-yl]benzoate copper(2+) salts
- Cas Number:
- 12237-63-7
- Molecular formula:
- C34H31N8O3Cu3Fe
- IUPAC Name:
- ferrate(4-), hexakis(cyano-C)-, Et 2-[6-(ethylamino)-3-(ethylimino)-2,7-dimethyl-3H-xanthen-9-yl]benzoate copper(2+) salts
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of substance:ferrate(4-), hexakis(cyano-C)-, Et 2-[6-(ethylamino)-3-(ethylimino)-2,7-dimethyl-3H-xanthen-9-yl]benzoate copper(2+) salts
- Appearance : red powder
- Common name: Pigment red 169
- Substance type: UVCBs-organometallic
Constituent 1
Method
- Target gene:
- Histidine for Salmonella strains and Tryptophan for E. coli strain
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- No data
- Additional strain / cell type characteristics:
- other: histidine auxotrophs (his-)
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- No data
- Additional strain / cell type characteristics:
- other: tryptophan auxotrophy (trp-)
- Cytokinesis block (if used):
- No data
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor-induced rat liver S-9 mix
- Test concentrations with justification for top dose:
- 0, 20, 100, 500, 2,500 or 5,000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: Due to the insolubility of the test substance in water, DMSO was selected as the vehicle, which had been
demonstrated to be suitable in bacterial reverse mutation tests and for which historical control data are available.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Remarks:
- Additional plates are treated with soft agar, S-9 mix, buffer, vehiele or the test substance but without the addition of tester strains
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- with S9
- Positive control substance:
- other: 2-aminoanthracene (2-AA)
- Remarks:
- strains: TA 1535, TA 100, TA 1537, TA 98: 2.5 µg/plate, dissolved in DMSO; Strain: Escherichia coli WP2 uvrA: 60 µg/plate, dissolved in DMSO
- Untreated negative controls:
- yes
- Remarks:
- Additional plates are treated with soft agar, S-9 mix, buffer, vehicle or the test substance but without the addition of tester strains
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- without S9
- Positive control substance:
- other: N-methyl-N'-nitro-N-nitrosuguanidine (MNNG)
- Remarks:
- Strains: TA 1535, TA 100: 5 µg/plate, dissolved in DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: 4-nitro-o-phenylendiamine (NOPD)
- Remarks:
- Strain: TA 98: 10 µg/plate, dissolved in DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- Strain: TA 1537: 100 µg/plate, dissolved in DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- Strain: E. coli WP2 uvrA: 10 µg/plate, dissolved in DMSO
- Details on test system and experimental conditions:
- Standard plate test (SPT) and preincubation test (PIT) both with and without metabolic activation (Aroclor-induced rat liver S-9 mix)
METHOD OF APPLICATION: in medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk
- Cell density at seeding (if applicable):
DURATION
- Preincubation period: For PIT: 20 mins
- Exposure duration: 48 - 72 hours
- Expression time (cells in growth medium): 48 - 72 hours
- Selection time (if incubation with a selection agent):
- Fixation time (start of exposure up to fixation or harvest of cells):
SELECTION AGENT (mutation assays):
SPINDLE INHIBITOR (cytogenetic assays):
STAIN (for cytogenetic assays):
NUMBER OF REPLICATIONS: Triplicate
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED:
NUMBER OF CELLS EVALUATED:
NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE (if in vitro cytogenicity study in mammalian cells):
CRITERIA FOR MICRONUCLEUS IDENTIFICATION:
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency; relative total growth; other:
- Any supplementary information relevant to cytotoxicity:
OTHER EXAMINATIONS:
- Determination of polyploidy:
- Determination of endoreplication:
- Methods, such as kinetochore antibody binding, to characterize whether micronuclei contain whole or fragmented chromosomes (if applicable):
- OTHER: - Rationale for test conditions:
- No data
- Evaluation criteria:
- The test chemical is considered positive in this assay if the following criteria are met:
A dose-related and reproducible increase in the nuinber of revertant colonies, i.e. about doubling of the spontaneous mutation rate in at least one tester strain either without S-9 mix or after adcling a metabolizing system.
A test substance is generally considered nonmutagenic in this test if:
The number of revertants for all tester strains were within the historical negative control range under all experimental conditions in two experiments carried out independently of each other. - Statistics:
- No data
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: No data
- Effects of osmolality: No data
- Evaporation from medium: No data
- Water solubility: No data
- Precipitation: Precipitation of the test substance was found from about 500 µg/plate onward.
- Definition of acceptable cells for analysis: No data
- Other confounding effects: No data
RANGE-FINDING/SCREENING STUDIES: No data
CYTOKINESIS BLOCK (if used)
- Distribution of mono-, bi- and multi-nucleated cells: No data
NUMBER OF CELLS WITH MICRONUCLEI
- Number of cells for each treated and control culture: No data
- Indication whether binucleate or mononucleate where appropriate: No data
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: No data
- Negative (solvent/vehicle) historical control data: No data
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: No data
- Other observations when applicable: No data - Remarks on result:
- other: No mutagenic potential
Any other information on results incl. tables
Standard plate assay
Table: Mutagenic potential
Strain TA1535 Without S9
Dose |
Rev |
M |
SD |
FAC |
DMSO |
16 |
20 |
3 |
1.0 |
21 |
||||
22 |
||||
20 µg |
20 |
20 |
1 |
1.0 |
19 |
||||
20 |
||||
100 µg |
21 |
20 |
1 |
1.0 |
19 |
||||
19 |
||||
500 µg |
18P |
19 |
1 |
1.0 |
20P |
||||
19P |
||||
2500 µg |
5P |
5 |
1 |
0.3 |
4P |
||||
6P |
||||
5000 µg |
5P |
3 |
2 |
0.2 |
3P |
||||
1P |
||||
MNNG 5.0µg |
1004 |
1002 |
24 |
50.9 |
977 |
||||
1024 |
||||
2-AA 2.5 µg |
|
|
|
|
Strain TA1535 With S9
Dose |
Rev |
M |
SD |
FAC |
TITRE |
DMSO |
18 |
19 |
2 |
1.0 |
29 |
18 |
22 |
||||
21 |
27 |
||||
20 µg |
19 |
18 |
1 |
1.0 |
|
18 |
|||||
18 |
|||||
100 µg |
15 |
14 |
1 |
0.7 |
|
13 |
|||||
14 |
|||||
500 µg |
17P |
17 |
2 |
0.9 |
|
19P |
|||||
19P |
|||||
2500 µg |
7P |
6 |
2 |
0.3 |
15 |
8P |
14 |
||||
4P |
20
|
||||
5000 µg |
0P |
|
|
|
0 |
0P |
0 |
||||
0P |
0 |
||||
2-AA |
176 |
171 |
14 |
9.0 |
|
155 |
|
||||
181 |
|
Strain TA100 Without S9
Dose |
Rev |
M |
SD |
FAC |
DMSO |
124 |
115 |
8 |
1.0 |
108 |
||||
113 |
||||
20 µg |
104 |
101 |
8 |
0.9 |
107 |
||||
94 |
||||
100 µg |
98 |
102 |
7 |
0.9 |
110 |
||||
99 |
||||
500 µg |
55P |
60 |
5 |
0.5 |
61P |
||||
65P |
||||
2500 µg |
11P |
8 |
3 |
0.1 |
5P |
||||
8P |
||||
5000 µg |
0P |
|
|
|
0P |
||||
0P |
||||
MNNG 5.0µg |
1312 |
1319 |
49 |
11.5 |
1273 |
||||
1371 |
||||
2-AA 2.5 µg |
|
|
|
|
Strain TA100 With S9
Dose |
Rev |
M |
SD |
FAC |
TITRE |
DMSO |
112 |
111 |
9 |
1.0 |
22 |
102 |
21 |
||||
120 |
29 |
||||
20 µg |
110 |
110 |
2 |
1.0 |
|
108 |
|||||
111 |
|||||
100 µg |
104 |
114 |
8 |
1.0 |
|
118 |
|||||
119 |
|||||
500 µg |
57P |
52 |
17 |
0.5 |
|
66P |
|||||
33P |
|||||
2500 µg |
5P |
5 |
3 |
0.0 |
1 |
8P |
2 |
||||
2P |
5 |
||||
5000 µg |
0P |
|
|
|
0 |
0P |
0 |
||||
0P |
0 |
||||
2-AA 2.5 µg |
1135 |
1274 |
180 |
11.4 |
|
1477 |
|||||
1210 |
Strain TA1537 Without S9
Dose |
Rev |
M |
SD |
FAC |
DMSO |
9 |
10 |
1 |
1.0 |
10 |
||||
10 |
||||
20 |
9 |
9 |
1 |
1.0 |
9 |
||||
10 |
||||
100 |
9 |
10 |
1 |
1.0 |
10 |
||||
11 |
||||
500 |
5P |
5 |
2 |
0.6 |
7P |
||||
4P |
||||
2500 |
1P |
1 |
0 |
0.1 |
1P |
||||
1P |
||||
5000 |
0P |
|
|
|
0P |
||||
0P |
||||
AAC 100 µg |
621 |
649 |
27 |
67.2 |
674 |
||||
653 |
||||
2-AA 2.5 µg |
|
|
|
|
Strain TA1537 With S9
Dose |
Rev |
M |
SD |
FAC |
TITRE |
DMSO |
11 |
11 |
1 |
1.0 |
38 |
11 |
29 |
||||
10 |
28 |
||||
20 µg |
9 |
9 |
2 |
0.9 |
|
8 |
|||||
11 |
|||||
100 µg |
7 |
8 |
1 |
0.8 |
|
9 |
|||||
9 |
|||||
500 µg |
8P |
8 |
0 |
0.8 |
|
8P |
|||||
8P |
|||||
2500 µg |
1P |
1 |
1 |
0.1 |
2 |
1P |
5 |
||||
2P |
1 |
||||
5000 µg |
0P |
|
|
|
0 |
0P |
0 |
||||
0P |
0 |
||||
AAC 100 µg
|
|
|
|
|
|
2-AA 2.5 µg |
173 |
185 |
13 |
17.5 |
|
198 |
|||||
185 |
Strain TA 98 Without S9
Dose |
Rev |
M |
SD |
FAC |
DMSO |
20 |
27 |
7 |
1.0 |
29 |
||||
33 |
||||
20 µg |
24 |
21 |
3 |
0.8 |
19 |
||||
21 |
||||
100 µg |
21 |
23 |
2 |
0.9 |
24 |
||||
25 |
||||
500 µg |
21P |
20 |
1 |
0.7 |
19P |
||||
19P |
||||
2500 µg |
2P |
3 |
1 |
0.1 |
3P |
||||
4P |
||||
5000 µg |
0P |
|
|
|
0P |
||||
0P |
||||
NOPD 10 µg |
937 |
945 |
25 |
34.6 |
925 |
||||
973 |
||||
2-AA 2.5 µg |
|
|
|
|
Strain TA 98 With S9
Dose |
Rev |
M |
SD |
FAC |
TITRE |
DMSO |
42 |
38 |
3 |
1.0 |
17 |
36 |
24 |
||||
36 |
24 |
||||
20 µg |
35 |
33 |
2 |
0.9 |
|
31 |
|||||
32 |
|||||
100 µg |
34 |
33 |
2 |
0.9 |
|
31 |
|||||
34 |
|||||
500 µg |
20P |
22 |
2 |
0.6 |
|
24P |
|||||
23P |
|||||
2500 µg |
11P |
8 |
3 |
0.2 |
2 |
8P |
2 |
||||
6P |
2 |
||||
5000 µg |
0P |
|
|
|
0 |
0P |
0 |
||||
0P |
0 |
||||
NOPD 10 µg |
|
|
|
|
|
2-AA 2.5 µg |
936 |
943 |
13 |
24.8 |
|
925 |
|||||
958 |
StrainE.coli WP2uvrA Without S9
Dose |
Rev |
M |
SD |
FAC |
DMSO |
36 |
36 |
1 |
1.0 |
37 |
||||
35 |
||||
20 µg |
31 |
32 |
4 |
0.9 |
37 |
||||
29 |
||||
100 µg |
34 |
32 |
3 |
0.9 |
33 |
||||
29 |
||||
500 µg |
29P |
32 |
3 |
0.9 |
31P |
||||
35P |
||||
2500 µg |
25P |
28 |
3 |
0.8 |
30P |
||||
30P |
||||
5000 µg |
15P |
18 |
3 |
0.5 |
17P |
||||
21P |
||||
ENNG 10 µg |
999 |
1009 |
18 |
28.0 |
998 |
||||
1029 |
||||
2-AA 60 µg |
|
|
|
|
Strain E.coli WP2 uvrAWith S9
Dose |
Rev |
M |
SD |
FAC |
TITRE |
DMSO |
39 |
40 |
2 |
1.0 |
40 |
42 |
45 |
||||
39 |
39 |
||||
20 µg |
35 |
32 |
3 |
0.8 |
|
31 |
|||||
29 |
|||||
100 µg |
37 |
35 |
3 |
0.9 |
|
37 |
|||||
31 |
|||||
500 µg |
31P |
31 |
1 |
0.8 |
|
31P |
|||||
30P |
|||||
2500 µg |
20P |
24 |
4 |
0.6 |
8 |
26P |
6 |
||||
27P |
7 |
||||
5000 µg |
12P |
12 |
1 |
0.3 |
0 |
12P |
0 |
||||
13P |
0 |
||||
ENNG 10 µg |
|
|
|
|
|
2-AA 60 µg |
326 |
314 |
40 |
7.9 |
|
347 |
|||||
269 |
Applicant's summary and conclusion
- Conclusions:
- According to the results of the present study, the test substance is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay with and without metabolic activation.
- Executive summary:
The test substance was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli, in a reverse mutation assay. The study was performed using Salmonella typhimurium strains TA 1535, TA 1537, TA 98 and TA 100 and E. coli WP2 uvrA. The test chemical was dissolved in DMSO and used at dose level of 0, 20, 100, 500, 2,500 or 5,000 µg/plate. Concurrent solvent and positive control chemicals were also included in the study. According to the results of the present study, the test substance pigment red 169 is not mutagenic in the Salmonella typhimurium /Escherichia coli reverse mutation assay with and without metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.